[BGLC] YoY Quarter Result on 31-Dec-2023 [#Q4]

Stock
[BGLC] BioNexus Gene Lab Corp.
Announcement Date
31-May-2024
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- 111.77%
YoY- 295.54%
Quarter Report
BGLC's Result
BGLC's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 2,273 2,840 3,245 11,360 53 9 65 80.78%
PBT 253 -127 197 1,435 -96 -63 -61 -
Tax -55 30 108 167 -4 0 4 -
NP 307 -157 89 1,269 -93 -63 -65 -
Tax Rate 21.74% - -54.72% -11.61% - - - -
Total Cost 1,966 2,997 3,156 10,092 146 72 130 57.22%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin 13.52 -5.53 2.75 11.17 -174.51 -669.43 -101.28 -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS 0.02 -0.01 0.01 -0.02 -0.01 -0.01 -0.01 -
EPS Diluted 0.02 -0.01 0.01 -0.02 -0.01 -0.01 -0.01 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.